Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$455.08 - $517.19 $8.74 Million - $9.93 Million
-19,200 Reduced 56.14%
15,000 $7.58 Million
Q2 2024

Aug 14, 2024

BUY
$468.04 - $548.53 $11.8 Million - $13.8 Million
25,200 Added 280.0%
34,200 $16.7 Million
Q1 2024

May 15, 2024

SELL
$515.08 - $576.87 $7.67 Million - $8.6 Million
-14,900 Reduced 62.34%
9,000 $4.86 Million
Q4 2023

Feb 14, 2024

BUY
$391.37 - $557.56 $8.53 Million - $12.2 Million
21,800 Added 1038.1%
23,900 $13.3 Million
Q2 2023

Aug 14, 2023

BUY
$450.7 - $503.61 $585,910 - $654,693
1,300 Added 162.5%
2,100 $1.05 Million
Q1 2023

May 15, 2023

SELL
$406.01 - $514.59 $1.83 Million - $2.32 Million
-4,500 Reduced 84.91%
800 $400,000
Q4 2022

Feb 14, 2023

SELL
$324.64 - $441.27 $1.2 Million - $1.63 Million
-3,700 Reduced 41.11%
5,300 $2.16 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.7B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.